Fiona McLaughlin

Board Member at Mestag Therapeutics

Fiona MacLaughlin is a Senior Director, Venture Investments, at Johnson & Johnson Development Corporation (Johnson & Johnson Innovation – JJDC, inc., the strategic venture arm of Johnson & Johnson. Prior to joining JJDC, Fiona was a Director at Inkef Capital, where she led both pharma and MedTech investments and held Board seats in a number of portfolio companies. A qualified pharmacist, Fiona is passionate about helping early-stage companies establish a value-building trajectory by engaging and challenging management and creating optimal development plans. Fiona began her career in biotech focusing on the development of non-viral gene therapy and other novel delivery solutions. A fundamental interest in philanthropy led her to the Wellcome Trust and a focus on translational funding, including establishing a fund to support the development of affordable healthcare technologies in India. Fiona’s transition to venture investing began with a move to Advent Life Sciences, where she was involved in helping shape and build a number of early-stage companies including Arrakis Therapeutics.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Mestag Therapeutics

Mestag was founded in 2020 by leading investigators and SV Health Investors to develop new medicines for people affected by inflammatory disease and cancer.


Employees

11-50

Links